Printer Friendly

Biotech vaccine okayed.

Biotech vaccine okayed

The Food and Drug Administration this week approved a hepatitis vaccine made by yeast saddled with hepatitis B virus genes (SN:7/27/85,p.55). The approval is the first for a genetically enginerred human vaccine and for a human pharmaceutical produced by yeast. While there is already a hepatitis B vaccine on the market, it is derived from blood. According to the July 24 NEW ENGLAND JOURNAL OF MEDICINE, the efficacy of the blood-derived vaccine can drop substantially over time: 15 percent of 635 men lost all protection within five years of vaccination.
COPYRIGHT 1986 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1986, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Science News
Date:Jul 26, 1986
Previous Article:Planting seeds for better drug delivery; researchers are attempting to expand the versatility of controlled-release drug implants.
Next Article:Cave clues suggest Stone Age cannibalism.

Related Articles
Nose-drop vaccine provides protection.
DNA vaccine set to tackle HIV infection.
HIV photos may bode ill for vaccine.
Brave new food: biotech vaccines in our corn and greens: Debi Athos questions the logic of feeding pharmaceutical fruits and vegetables to the masses.
He took a leap, now he's FLYING HIGH.
Risk factor: throat cancer linked to virus spread by sex.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters